Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,110 | -36,854 | -4,957 | -53,504 | -26,840 |
| Depreciation Amortization | 2,628 | 1,469 | 542 | 1,905 | 1,417 |
| Accounts receivable | -2,585 | -3,982 | -524 | -6,016 | -18,283 |
| Accounts payable and accrued liabilities | -1,324 | -1,210 | -2,665 | 7,577 | 2,354 |
| Other Working Capital | 5,452 | 543 | -26,230 | -19,260 | -32,933 |
| Other Operating Activity | 26,519 | 18,429 | 8,249 | 9,945 | 22,707 |
| Operating Cash Flow | $-46,420 | $-21,605 | $-25,585 | $-59,353 | $-51,578 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,978 | -14,679 | -3,797 | -2,216 | -727 |
| Purchase Of Investment | -218,657 | -106,205 | -35,526 | -837,219 | -215,383 |
| Sale Of Investment | 343,986 | 198,078 | 84,311 | 505,528 | 169,505 |
| Other Investing Activity | 0 | 0 | 0 | 571 | 571 |
| Investing Cash Flow | $107,351 | $77,194 | $44,988 | $-333,336 | $-46,034 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,293 | 2,913 | 1,822 | 335,880 | 96,101 |
| Other Financing Activity | -207 | 0 | 0 | -720 | 0 |
| Financing Cash Flow | $5,086 | $2,913 | $1,822 | $335,160 | $96,101 |
| Beginning Cash Position | 14,031 | 14,031 | 14,031 | 71,560 | 71,560 |
| End Cash Position | 80,048 | 72,533 | 35,256 | 14,031 | 70,049 |
| Net Cash Flow | $66,017 | $58,502 | $21,225 | $-57,529 | $-1,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,420 | -21,605 | -25,585 | -59,353 | -51,578 |
| Capital Expenditure | -17,978 | -14,679 | -3,797 | -2,216 | -727 |
| Free Cash Flow | -64,398 | -36,284 | -29,382 | -61,569 | -52,305 |